Related Experiment Video
Updated: Jun 25, 2026
12:10
Retzius-Sparing Robot-Assisted Radical Prostatectomy
Published on: May 19, 2022
Outcomes of robotic assisted radical prostatectomy
Prokar Dasgupta1, Roger S Kirby
1Guy's and St. Thomas' Hospitals, King's College London School of Medicine, London, UK. prokarurol@gmail.com
Summary
Robot-assisted radical prostatectomy (RARP) offers potential benefits over open surgery, including less blood loss and pain. While promising for cancer control, continence, and potency, more randomized data is needed to confirm its superiority over standard laparoscopy.
Area of Science:
- Urology
- Surgical Oncology
- Minimally Invasive Surgery
Background:
- Robot-assisted radical prostatectomy (RARP) is an emerging treatment for localized prostate cancer.
- Adoption of RARP in Europe is slower, potentially due to existing laparoscopic expertise and program setup costs.
Purpose of the Study:
- To review the current literature on RARP outcomes, focusing on oncologic control, urinary continence, and erectile potency (the 'trifecta').
Main Methods:
- Literature review of studies comparing RARP with open prostatectomy and laparoscopy.
- Analysis of oncologic, continence, and potency data from available studies.
Main Results:
- Preliminary data suggests RARP may offer advantages over open prostatectomy, including reduced blood loss, pain, and hospital stay, with lower positive margin rates.
- Intra-institutional studies indicate good postoperative continence and potency rates with RARP.
- No definitive data currently shows RARP superiority over standard laparoscopy, though rapid adoption is noted.
Conclusions:
- RARP shows promising preliminary outcomes for the 'trifecta' in localized prostate cancer treatment.
- Further randomized controlled trials are necessary to establish definitive advantages over existing techniques.
- The rapid evolution and adoption of RARP technology in surgical units is significant.